Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥39.2B | ¥43.5B | −9.9% |
| Operating Income | ¥1.4B | ¥4.5B | −69.2% |
| Ordinary Income | ¥2.1B | ¥5.5B | −62.1% |
| Net Income | ¥1.9B | ¥3.8B | −49.8% |
| ROE | 2.4% | 5.0% | - |
Executive Summary
For the cumulative Q3 of FY2026, profitability clearly deteriorated, as Operating Income contracted substantially in addition to the decline in Revenue. Revenue was ¥39.2B (down -9.9% YoY), Operating Income was ¥1.4B (down -69.2%), Ordinary Income was ¥2.1B (down -62.1%), and Net Income (Net Income attributable to the current period) was ¥1.9B (down -49.8%). The decline in profits exceeding the decrease in Revenue was primarily attributable to SG&A expenses remaining high at ¥6.7B against a gross margin of 20.6%, resulting in reduced fixed-cost absorption capacity. Ordinary Income and Net Income were partially supported by dividend income of ¥0.7B and extraordinary income of ¥0.8B, and the earnings power viewed solely from the core business remained at the level indicated by the 3.5% Operating Income margin.
Factors Affecting Performance
【Revenue】Revenue was ¥39.2B, down 9.9% YoY. Progress against the full-year forecast (¥66.5B, up +0.4% YoY) was 59.0%, indicating that cumulative performance is below the full-year growth forecast at this stage. Although segment-level disclosure is not available, sluggish demand or deterioration in sales volume and pricing is believed to have been the main driver of the decline in Revenue.
【Profit and Loss】Profit contracted at a rate exceeding the decline in Revenue, with Operating Income falling to ¥1.4B (down -69.2%) and the Operating Income margin declining to 3.5%. Against gross profit of ¥8.1B (gross margin of 20.6%), SG&A expenses remained high at ¥6.7B, confirming high operating leverage whereby the fixed-cost burden pressured Operating Income. Ordinary Income was ¥2.1B (down -62.1%), with non-operating income of ¥0.9B, including dividend income of ¥0.7B, adding to core business profit. Net Income was ¥1.9B (down -49.8%), supported by extraordinary income of ¥0.8B (after offsetting extraordinary losses of ¥0.2B, including losses on the sale and disposal of fixed assets), meaning that temporary factors supported Net Income despite the decline in Revenue and earnings. In conclusion, the current period saw both a decline in Revenue and earnings.
Key Financial Metrics
【Profitability】The Operating Income margin was 3.5% and the Net Income margin was 4.8%, both significantly lower than in the same period of the previous year. Under DuPont analysis, ROE of 2.4% is derived from a Net Income margin of 4.8%, total asset turnover of 0.334x, and financial leverage of 1.50x, indicating that low profitability was the primary factor. ROIC was also low at 1.5%, suggesting that invested capital is not generating sufficient profits.【Cash Quality】Accounts receivable of ¥19.6B and inventories of ¥22.6B (including ¥22.6B of finished goods) account for high proportions of total assets, while annualized DSO of 137 days, DIO of 268 days, and CCC of 327 days indicate a prolonged working capital cycle.【Investment Efficiency】Total asset turnover of 0.334x indicates low asset efficiency, while investment securities of ¥21.6B (18.4% of total assets) carry a meaningful weight in the asset composition.【Financial Soundness】The capital structure is sound, with an Equity Ratio of 66.6% and a debt-to-equity ratio of 0.50x. However, short-term borrowings of ¥8.0B exceed cash and deposits of ¥3.5B, leaving the cash-to-short-term liabilities ratio at only 0.43x. The current ratio of 198.9% and quick ratio of 116.3% indicate overall liquidity headroom, while interest coverage of 13.23x supports debt-servicing capacity.
Cash Flow Analysis
Although detailed disclosure of the cash flow statement is unavailable, cash flow trends can be inferred from changes in the balance sheet. Cash and deposits stood at ¥3.5B, down from ¥4.1B in the previous year, while accounts receivable were ¥19.6B (down from ¥24.8B in the previous year) and inventories were ¥22.6B (up from ¥18.9B in the previous year), indicating increased funds tied up in inventory. With the combined balance of accounts receivable and inventories substantially exceeding accounts payable of ¥8.8B, the long annualized CCC of 327 days indicates a structure in which cash generation from operating activities is easily constrained by the accumulation of inventory and accounts receivable. Short-term borrowings were ¥8.0B, up from ¥7.0B in the previous year, suggesting that the expansion of working capital may be being funded through short-term financing.
Earnings Quality
The current period’s earnings include a considerable amount of items differing from recurring core business profit. Dividend income accounted for ¥0.7B of non-operating income of ¥0.9B, equivalent to approximately 51% of Operating Income of ¥1.4B. Accordingly, an assessment based solely on the core business should use the 3.5% Operating Income margin as the benchmark. In addition, extraordinary income of ¥0.8B was recorded in Profit Before Tax (after offsetting losses on the sale and disposal of fixed assets and other items, including extraordinary losses of ¥0.2B), meaning that a substantial portion of Net Income of ¥1.9B was supported by non-recurring items. From an accruals perspective, inventories—particularly finished goods inventory of ¥22.6B—accumulated despite the decline in Revenue, creating a situation in which a divergence may easily arise between accounting earnings and actual cash-generation capacity. In light of these factors, the level of Net Income for the current period should be interpreted as including investment income and temporary factors, rather than as an indication of sustainable earnings power.
Earnings Forecast and Guidance
Progress against the full-year company forecasts was 59.0% for Revenue, 39.1% for Operating Income, 48.4% for Ordinary Income, and 62.7% for Net Income. Compared with the standard cumulative Q3 progress benchmark of 75%, Operating Income was 35.9pt and Ordinary Income was 26.6pt below the benchmark, highlighting the delay on the profit front. Although the 62.7% progress rate for Net Income is relatively high, it includes contributions from dividend income and extraordinary income and is therefore difficult to assess as sustainable progress driven by core business improvement. To achieve the full-year forecast of Revenue of ¥66.5B and Operating Income of ¥3.5B, standalone Q4 Operating Income of ¥2.1B will be required, exceeding cumulative Q3 Operating Income of ¥1.4B.
Shareholder Returns
The dividend as of Q2 was ¥0, while the full-year forecast dividend is ¥70 per share. Based on forecast full-year EPS of ¥229.64, the Payout Ratio is approximately 30.5% (total dividends ÷ forecast full-year Net Income). If the forecast earnings are achieved, the Payout Ratio itself will remain at a conservative level. However, against forecast full-year Net Income of ¥3.0B, cumulative Q3 Net Income was ¥1.9B and Operating Income progress was 39.1%, making the securing of Q4 earnings, which is a prerequisite for paying the dividend, a key focus going forward.
Risk Factors
-
Prolonged inventory and working capital cycle: Inventories of ¥22.6B, centered on finished goods inventory of ¥22.6B, have accumulated, resulting in an annualized DIO of 268 days and an annualized CCC of 327 days, indicating a prolonged cash conversion cycle. If the decline in Revenue continues, further pressure on profit margins from inventory write-downs and discount sales is a concern.
-
Dependence on short-term funding: Short-term borrowings of ¥8.0B exceed cash and deposits of ¥3.5B, leaving the cash-to-short-term liabilities ratio at only 0.43x. Short-term liabilities account for a high proportion of total liabilities, creating a structure in which performance is susceptible to refinancing conditions and progress in cash collection.
-
Declining core business earnings power: The Operating Income margin of 3.5% and ROIC of 1.5% are both low, and SG&A expenses (¥6.7B) are not being sufficiently absorbed relative to the decline in Revenue. Operating leverage is high, creating a risk that Operating Income will contract further if sluggish demand continues.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 3.5% | 8.6% (4.3%–12.7%) | −5.1pt |
| Net Income Margin | 4.8% | 6.4% (2.8%–10.3%) | −1.6pt |
The Company’s profitability is significantly below the industry median and ranks toward the lower end among manufacturing companies.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | −9.9% | 3.3% (-2.1%–8.9%) | −13.2pt |
The Revenue growth rate is also significantly below the industry median, indicating that the Company is underperforming its industry peers in terms of growth.
※Source: Compiled by the Company
Key Takeaways from the Financial Results
-
The decline in core business profitability, as indicated by the Operating Income margin of 3.5% and ROIC of 1.5%, is the central issue in these financial results. The Company has limited capacity to absorb SG&A expenses amid the decline in Revenue, and high operating leverage is amplifying fluctuations in earnings.
-
The prolonged working capital cycle indicated by finished goods inventory of ¥22.6B, annualized DIO of 268 days, and annualized CCC of 327 days is a structural issue requiring monitoring from the perspective of cash-generation capacity.
-
Ordinary Income and Net Income were partially supported by dividend income of ¥0.7B and extraordinary income of ¥0.8B. Achieving the full-year Operating Income forecast requires securing core business profit of ¥2.1B in Q4. The delay in progress is particularly significant for Operating Income and Ordinary Income.
This report is an earnings analysis document automatically generated by AI through analysis of XBRL financial results summary data. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available financial results data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
FY2026 Q3 performance was weak, with lower sales and a pronounced erosion of operating profitability despite positive non-operating and extraordinary items. Revenue declined 9.9% YoY to ¥3.92bn. Operating income fell 69.2% YoY to ¥137m, substantially underperforming the sales decline. Gross profit decreased 26.6% YoY to ¥807m as cost of sales fell only 4.3% YoY. The gross margin contracted by 469bp YoY to 20.6% from 25.3%. SG&A expenses increased 2.5% YoY to ¥669m while revenue declined, lifting the SG&A-to-sales ratio by 207bp to 17.1%. Consequently, the operating margin compressed by 678bp YoY to 3.5% from 10.3%. Ordinary income declined 62.1% YoY to ¥208m, but dividend income of ¥70m represented 33.8% of ordinary income and cushioned weaker core operations. Profit before tax was ¥266m, supported by a net extraordinary gain of ¥58m, principally including ¥30m of insurance income. Net income declined 49.8% YoY to ¥188m, with the net margin falling 382bp to 4.8%. The cumulative Q3 result equates to 58.9% of the full-year revenue forecast, 39.1% of the operating-income forecast, 48.4% of the ordinary-income forecast, and 62.7% of the net-income forecast. Reaching the full-year plan requires Q4 revenue of ¥2.73bn and operating income of ¥213m, implying a 7.8% Q4 operating margin versus 3.5% year-to-date. This required operating-margin recovery is material and makes achievement of the operating-profit forecast dependent on a sharp improvement in volume, product mix, pricing, or manufacturing cost absorption. The balance sheet remains equity-rich, with a 66.6% equity ratio, current ratio of 198.9%, and debt-to-equity ratio of 0.50x. However, cash of ¥345m covers only 0.43x short-term borrowings, while extended working-capital metrics indicate a long cash-conversion cycle. The key near-term analytical issue is whether the elevated finished-goods inventory and slow collection cycle reverse sufficiently to support the needed Q4 earnings recovery and refinancing flexibility.
Profitability Analysis
The annualized DuPont ROE is 3.2%, comprising a 4.8% net profit margin, 0.445x asset turnover, and 1.50x financial leverage. The largest deterioration is in operating profitability rather than leverage: the operating margin fell to 3.5%, below the 5% efficiency warning threshold, from 10.3% in the prior-year period. The gross-margin decline to 20.6% indicates that the reduction in cost of sales did not keep pace with the 9.9% sales contraction, consistent with unfavorable product mix, pricing pressure, lower capacity utilization, or input-cost absorption. Operating leverage was negative because SG&A rose 2.5% while sales fell, increasing the SG&A ratio to 17.1%. The 3.2% annualized ROE is also restrained by low annualized asset turnover of 0.445x, reflecting the substantial asset base relative to sales. Financial leverage of 1.50x is moderate and is not the principal source of weak shareholder returns. Annualized ROA is approximately 2.2%, using annualized nine-month net income and average total assets, also indicating low capital productivity. The five-factor analysis shows a 0.707 tax burden, broadly normal for the reported 29.1% effective tax rate. The interest burden exceeds 1.0x because profit before tax benefited from non-operating and extraordinary gains; it should not be interpreted as an operating funding advantage. Interest coverage of 13.23x remains sound, but this coverage is based on a materially lower operating-income base. Dividend income of ¥70m, together with other non-operating income, means ordinary profit is more resilient than operating profit, but this income is not a substitute for restoring manufacturing margins. The net extraordinary gain of ¥58m equaled about 30.6% of reported net income, reducing the comparability of bottom-line earnings with recurring operating performance.
Growth Assessment
Revenue contracted 9.9% YoY to ¥3.92bn, and the much steeper 69.2% decline in operating income demonstrates adverse earnings sensitivity to lower sales. Gross profit fell faster than revenue, while SG&A did not decline, indicating that current profit pressure is not solely a volume issue. Full-year guidance calls for revenue of ¥6.65bn, up 0.4% YoY, but operating income of ¥350m, down 35.3% YoY, and net income of ¥300m, down 17.4% YoY. The Q3 revenue progress rate of 58.9% is 16.1 percentage points below the conventional 75% Q3 pace. Operating-income progress of 39.1% is 35.9 percentage points below the conventional pace, representing the most demanding element of the forecast. Ordinary-income progress of 48.4% is also below the standard pace, although investment dividend income offers some support. Net-income progress of 62.7% is comparatively stronger because extraordinary gains have supported the year-to-date result. The implied Q4 operating margin of 7.8% is above the year-to-date 3.5% margin but below the prior-year nine-month 10.3% margin, making the target possible only with a significant sequential normalization. Inventories increased 19.5% YoY to ¥2.26bn while sales declined, and finished goods account for the disclosed inventory balance. This combination elevates the risk that demand normalization takes longer than expected or that inventory valuation and discounting pressure gross margin. For a chemical manufacturer, the principal business variables are customer demand, product mix, utilization rates, raw-material and energy-cost pass-through, and potential price competition; each can affect the required Q4 margin recovery.
Financial Health
Financial solvency is generally conservative: total equity was ¥7.82bn, the equity ratio was 66.6%, debt-to-equity was 0.50x, and debt-to-capital was 15.5%. Total interest-bearing debt was ¥1.44bn, comprising ¥800m of short-term loans and ¥635m of long-term loans. The current ratio of 198.9% and quick ratio of 116.3% indicate that current assets exceed current liabilities and that liquidity is adequate on a broad balance-sheet basis. Working capital was ¥2.71bn. Nevertheless, the short-term debt ratio was 55.7%, triggering refinancing-risk concern because more than half of interest-bearing debt is short term. Cash and deposits of ¥345m covered only 0.43x short-term loans, below the 0.5x alert threshold; the company is therefore reliant on receivable collection, inventory monetization, operating cash generation, and/or bank refinancing rather than cash alone to meet short-term funding needs. This is a maturity-management issue rather than a balance-sheet solvency issue, given the current ratio and moderate leverage. Interest coverage of 13.23x provides a meaningful debt-service cushion, although declining operating income should be monitored. Investment securities totaled ¥2.16bn, or 18.4% of total assets, and valuation differences on securities increased to ¥830m from ¥547m. This portfolio is a source of financial asset value and dividend income, but also introduces market-value sensitivity into equity and non-operating income. Intangible assets rose ¥27m, or 92.0% YoY, to ¥57m, though they remain only 0.5% of total assets and do not create a material intangible-asset concentration risk. Property, plant and equipment represented 34.1% of total assets, consistent with a manufacturing asset base. No debt-to-equity or current-ratio warning is indicated because D/E is well below 2.0x and the current ratio is well above 1.0x.
Notable B/S Changes
Intangible assets: +¥27m (+92.0%) to ¥57m - significant percentage growth, but still only 0.5% of total assets; balance-sheet concentration and amortization risk remain limited. Accounts receivable: -¥522m (-21.0%) to ¥1.96bn - favorable absolute reduction and a partial liquidity offset, although the reported annualized DSO of 137 days remains elevated. Investment securities: +¥397m (+22.5%) to ¥2.16bn - a large financial-asset exposure relative to the company’s scale, supporting dividend income but increasing sensitivity of equity to market valuations. Inventories: +¥369m (+19.5%) to ¥2.26bn - not a >25% change, but material in the context of declining sales and reported inventory-days alerts; monitor finished-goods conversion and valuation risk.
Cash Flow Quality
The reported information does not provide operating, investing, or financing cash-flow figures, so cash-conversion and free-cash-flow coverage cannot be quantified. Balance-sheet working-capital indicators nevertheless point to a potentially demanding cash-generation profile. Accounts receivable declined ¥522m YoY to ¥1.96bn, which is constructive in absolute terms, but the annualized DSO alert remains high at 137 days and signals slow cash collection relative to sales. Inventories rose ¥369m YoY to ¥2.26bn despite lower revenue. Finished goods were ¥2.26bn, raw materials were ¥610m, and work in process was ¥179m. The inventory-days alerts of 199 days and 268 days, under their respective reported calculation scopes, both materially exceed manufacturing efficiency benchmarks and indicate slow inventory conversion. The 327-day annualized cash-conversion-cycle alert is particularly material because a long operating cycle can absorb liquidity even when the current ratio appears strong. The high DSO, high inventory days, and long cash-conversion cycle together are the root cause of the working-capital quality concern. In a chemical manufacturing context, these indicators may reflect long customer qualification cycles, order timing, deliberate stocking, or weaker end-demand, but the concurrent decline in sales raises the risk of excess finished goods. The impact is reduced liquidity flexibility, potential inventory markdown or valuation risk, and greater dependence on short-term funding. The decline in trade receivables partially offsets inventory growth, but does not eliminate the need to monitor inventory normalization and customer collections. The absence of cash-flow data prevents assessment of operating-cash-flow-to-net-income conversion, accrual quality, free cash flow, or cash coverage of capital investment and dividends.
Dividend Sustainability
The full-year dividend forecast is ¥70 per share, while the Q2 dividend per share was ¥0. Based on forecast EPS of ¥229.64, the implied dividend payout ratio is approximately 30.5%. This payout ratio is below the 60% sustainability benchmark and is modest relative to forecast net income of ¥300m. The implied aggregate annual dividend is approximately ¥91m using average shares of 1.306 million, leaving a meaningful portion of forecast earnings retained. Balance-sheet leverage is moderate, which supports dividend capacity. However, year-to-date operating income is only 39.1% of the full-year target, and working-capital efficiency is weak, so the ultimate cash funding capacity should be assessed against Q4 inventory conversion and operating cash generation. The stated payout ratio refers only to dividends; no share-buyback information is used in calculating it. The forecast dividend therefore appears earnings-covered on the disclosed forecast, but sustainability depends on restoration of recurring operating profitability rather than non-operating dividends and extraordinary gains.
Risk Assessment
Business risks include Demand, product-mix, and capacity-utilization risk: revenue declined 9.9% YoY and operating income declined 69.2% YoY, showing high earnings sensitivity to lower sales., Margin-recovery risk: the gross margin contracted 469bp to 20.6% and the operating margin contracted 678bp to 3.5%; the FY forecast requires a 7.8% implied Q4 operating margin., Inventory valuation and obsolescence risk: inventories increased 19.5% YoY to ¥2.26bn while sales declined, and the reported inventory-days alerts of 199 and 268 days are both well above normal manufacturing benchmarks., Chemical-manufacturing input-cost and energy-cost risk: adverse movements in raw materials, utilities, and customer price pass-through could further limit gross-margin recovery., Customer collection and working-capital risk: annualized DSO of 137 days and a 327-day cash conversion cycle can delay conversion of accounting earnings into liquidity..
Financial risks include Refinancing risk: 55.7% of interest-bearing debt is short term, above the 40% alert threshold, requiring active rollover and liquidity management., Cash liquidity stress: cash-to-short-term-debt is 0.43x, below the 0.5x threshold, although current and quick ratios remain healthy., Capital-efficiency risk: annualized ROE is 3.2%, annualized ROA is approximately 2.2%, and the ROIC alert is 1.5%, all below customary return thresholds., Investment-security market risk: investment securities of ¥2.16bn and associated valuation differences expose equity to market-price movements..
Key concerns include The low-operating-efficiency alert is warranted because the 3.5% EBIT margin is below 5%; the primary investment implication is that fixed-cost absorption and gross-margin recovery are necessary for earnings normalization., The high-receivable-days alert is warranted because 137 days materially exceeds the 60-day warning level; even with lower receivables YoY, the collection cycle remains slow relative to annualized sales., The duplicate high-inventory-days alerts, at 199 and 268 days under alternative scopes, both point in the same direction: inventory conversion is slow and the finished-goods balance requires close monitoring., The long-CCC alert is warranted at 327 days; its likely impact is greater short-term borrowing dependence and reduced resilience if demand weakens further., Reported net income includes a net extraordinary gain of ¥58m and substantial dividend income, so recurring operating earnings are weaker than headline net income suggests..
Investment Implications
Key takeaways include The central issue is an operating-margin collapse to 3.5%, driven by lower gross margin and SG&A deleverage., The balance sheet is well capitalized, with a 66.6% equity ratio and 0.50x D/E, but near-term liquidity management is constrained by short-term debt concentration and low cash coverage., FY guidance embeds a substantial Q4 recovery, especially in operating profit, after weak nine-month progress., Working-capital intensity is high, led by inventory growth and long reported collection and inventory cycles., The forecast ¥70 DPS implies a moderate 30.5% dividend payout ratio, but recurring cash generation is the key determinant of dividend resilience..
Metrics to watch include Q4 revenue and operating margin versus the implied ¥2.73bn revenue and ¥213m operating-income requirement, Gross margin and SG&A-to-sales ratio, Finished-goods inventory balance and inventory days, Accounts receivable, annualized DSO, and cash conversion cycle, Short-term debt rollover, cash-to-short-term-debt ratio, and interest coverage, Contribution of dividend income and extraordinary items relative to recurring operating profit.
Regarding relative positioning, The company presents a stronger capital structure than a highly leveraged manufacturer, but its current profitability, annualized capital returns, and working-capital efficiency are weak relative to standard manufacturing benchmarks. Its sizeable investment-security portfolio and dividend income provide some earnings and balance-sheet support, while also making reported profit less directly representative of core manufacturing performance.